Sign In

Login

Password

Forgot Password ? Sign Up

K252a (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "K252a" in Japanese language version.

refsWebsite
Global rank Japanese rank
11nih.gov
4th place
24th place
9doi.org
2nd place
6th place
1fermentek.co.il
low place
low place

doi.org

  • Rüegg UT, Burgess GM (1989). “Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases”. Trends Pharmacol. Sci. 10 (6): 218-220. doi:10.1016/0165-6147(89)90263-0. PMID 2672462. 
  • Elliott LH, Wilkinson SE, Sedgwick AD, Hill CH, Lawton G, Davis PD, Nixon JS (1990). “K252a is a potent and selective inhibitor of phosphorylase kinase”. Biochem. Biophys. Res. Commun. 171 (1): 148-154. doi:10.1016/0006-291X(90)91369-4. PMID 2393389. 
  • Simpson DL, Dickens G, Doll S, Koizumi S, Tocco M, Okuda O, Oshima M, Rudkin BB, Brightman M, Guroff G (1991). “Differentiation of PC12 cells with K-ras: comparison with nerve growth factor”. J. Neurosci. Res. 28 (4): 486-496. doi:10.1002/jnr.490280405. PMID 1651400. 
  • Chin LS, Murray SF, Doherty PF, Singh SK (1999). “K252a induces cell cycle arrest and apoptosis by inhibiting Cdc2 and Cdc25c”. Cancer Invest. 17 (6): 391-395. doi:10.3109/07357909909021430. PMID 10434949. 
  • Hashimoto S (1988). “K-252a, a potent protein kinase inhibitor, blocks nerve growth factor-induced neurite outgrowth and changes in the phosphorylation of proteins in PC12h cells”. J. Cell. Biol. 107 (4): 1531-1539. doi:10.1083/jcb.107.4.1531. PMC 2115256. PMID 2844830. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2115256/. 
  • Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, Kaneko M (1987). “K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases”. Biochem. Biophys. Res. Commun. 142 (2): 436-440. doi:10.1016/0006-291X(87)90293-2. PMID 3028414. 
  • Hirayama E, Sasao N, Yoshimasu S, Kim J (2001). “K252a, an indrocarbazole derivative, causes the membrane of myoblasts to enter a fusion-capable state”. Biochem. Biophys. Res. Commun. 285 (5): 1237-1243. doi:10.1006/bbrc.2001.5327. PMID 11478789. 
  • Borasio GD (1990). “Differential effects of the protein kinase inhibitor K-252a on the in vitro survival of chick embryonic neurons”. Neurosci. Lett. 108 (1-2): 207-212. doi:10.1016/0304-3940(90)90732-O. PMID 2304631. 
  • Wood JL, Stoltz BM, Dietrich H-J (1995). “Total synthesis of (+)- and (−)-K252a”. J. Am. Chem. Soc. 117 (41): 10413–10414. doi:10.1021/ja00146a039. 

fermentek.co.il

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Rüegg UT, Burgess GM (1989). “Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases”. Trends Pharmacol. Sci. 10 (6): 218-220. doi:10.1016/0165-6147(89)90263-0. PMID 2672462. 
  • Elliott LH, Wilkinson SE, Sedgwick AD, Hill CH, Lawton G, Davis PD, Nixon JS (1990). “K252a is a potent and selective inhibitor of phosphorylase kinase”. Biochem. Biophys. Res. Commun. 171 (1): 148-154. doi:10.1016/0006-291X(90)91369-4. PMID 2393389. 
  • Simpson DL, Dickens G, Doll S, Koizumi S, Tocco M, Okuda O, Oshima M, Rudkin BB, Brightman M, Guroff G (1991). “Differentiation of PC12 cells with K-ras: comparison with nerve growth factor”. J. Neurosci. Res. 28 (4): 486-496. doi:10.1002/jnr.490280405. PMID 1651400. 
  • Chin LS, Murray SF, Doherty PF, Singh SK (1999). “K252a induces cell cycle arrest and apoptosis by inhibiting Cdc2 and Cdc25c”. Cancer Invest. 17 (6): 391-395. doi:10.3109/07357909909021430. PMID 10434949. 
  • Tapley P, Lamballe F, Barbacid M (1992). “K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors”. Oncogene 7 (2): 371-381. PMID 1312698. 
  • Hashimoto S (1988). “K-252a, a potent protein kinase inhibitor, blocks nerve growth factor-induced neurite outgrowth and changes in the phosphorylation of proteins in PC12h cells”. J. Cell. Biol. 107 (4): 1531-1539. doi:10.1083/jcb.107.4.1531. PMC 2115256. PMID 2844830. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2115256/. 
  • Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, Kaneko M (1987). “K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases”. Biochem. Biophys. Res. Commun. 142 (2): 436-440. doi:10.1016/0006-291X(87)90293-2. PMID 3028414. 
  • Hirayama E, Sasao N, Yoshimasu S, Kim J (2001). “K252a, an indrocarbazole derivative, causes the membrane of myoblasts to enter a fusion-capable state”. Biochem. Biophys. Res. Commun. 285 (5): 1237-1243. doi:10.1006/bbrc.2001.5327. PMID 11478789. 
  • Borasio GD (1990). “Differential effects of the protein kinase inhibitor K-252a on the in vitro survival of chick embryonic neurons”. Neurosci. Lett. 108 (1-2): 207-212. doi:10.1016/0304-3940(90)90732-O. PMID 2304631. 

ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov